Purpose: Coding variants in the optineurin gene (OPTN, GLC1E) have been reported to play a role in primary open-angle glaucoma (POAG) in various populations. This study investigated the role of OPTN sequence variants in patients with POAG in Ghana (West Africa).
Methods: This is a case-control study of unrelated Ghanaian POAG cases and non-glaucomatous controls.
Purpose Of Review: To review recent trends in genetic testing in medicine as they apply to newly evolving tests for patients with glaucoma.
Recent Findings: The utilization of powerful molecular methods for genetic testing is now entering its early stages in the practice of medicine in general, and with testing, many issues, both medical and societal, have been raised. Only recently has testing for a disease risk factor in primary open angle glaucoma (POAG) become available.